Ashley Birkett

Program Leader, Malaria Vaccine Initiative Leader, Malaria Disease Area, Path Center for Vaccine Innovation & Access at PATH

Ashley Birkett

Ashley Birkett

Program Leader, Malaria Vaccine Initiative Leader, Malaria Disease Area, Path Center for Vaccine Innovation & Access at PATH

Biography

Ashley Birkett, PhD, leads PATH’s Malaria Vaccine Initiative (MVI), which drives the development of safe and effective vaccines for the fight against malaria. MVI works to identify potentially promising malaria vaccine candidates, establish product development partnerships to move candidates through the development process, and increase access to a successful malaria vaccine in the countries that need it most. He also leads the malaria disease area of PATH’s Center for Vaccine Innovation and Access.

Before being named director, Dr. Birkett served as MVI’s deputy director, serving simultaneously as director of research and development (R&D)—the latter a position he held since joining PATH in 2008. As director of R&D, he led MVI’s efforts to support the development of transmission-blocking vaccines. He also guided MVI’s portfolio of evaluation technology projects, which are developing and refining ways to assess vaccine efficacy prior to large-scale field trials, and provided technical support across the range of MVI’s vaccine development programs, including the RTS,S program.

Dr. Birkett has more than 20 years of vaccine development experience, primarily with biotechnology companies, where he successfully advanced novel influenza and malaria vaccine candidates from research through first-in-human clinical studies. Prior to joining MVI, he was senior director of Preclinical Research at Acambis (now Sanofi Pasteur Biologics Co.), where he had responsibility for the company’s global preclinical vaccine research portfolio, with a special focus on influenza and adjuvant technology identification. Prior to Acambis, he played a similar role at Apovia Inc., first as senior director of Research and subsequently as vice president of Preclinical Development.

Dr. Birkett earned a PhD in Biochemistry and Molecular Biophysics from Virginia Commonwealth University; he has a BSc (Honors) in Applied Biological Sciences from the University of the West of England in the United Kingdom.

Overview
RelSci Relationships

173

Relationships
RelSci Relationships are individuals Ashley Birkett likely has professional access to. A relationship does not necessarily indicate a personal connection.

Lecturer in Management at Stanford University - Stanford Graduate School of Business

Relationship likelihood: Strong

Director, Research & Development at PATH Malaria Vaccine Initiative

Relationship likelihood: Strong

Deputy Chief Operating Officer at PATH

Relationship likelihood: Strong

Chief Data Officer at PATH

Relationship likelihood: Strong

Chief Human Resources Officer at PATH

Relationship likelihood: Strong

Global Head of Policy, Access & Introduction, Path Center for Vaccine Innovation & Access at PATH

Relationship likelihood: Strong

Global Head, Clinical, Path Center for Vaccine Innovation & Access at PATH

Relationship likelihood: Strong

Chief of Strategic Finance at PATH

Relationship likelihood: Strong

Global Head, Regulatory, Path Center for Vaccine Innovation & Access at PATH

Relationship likelihood: Strong

Chief Strategic Partnerships & Philanthropy Officer at PATH

Relationship likelihood: Strong

Paths to Ashley Birkett
Potential Connections via
Relationship Science
You
Ashley Birkett
Program Leader, Malaria Vaccine Initiative Leader, Malaria Disease Area, Path Center for Vaccine Innovation & Access at PATH
Career History
Director, Research & Development
Current
Program Leader, Malaria Vaccine Initiative Leader, Malaria Disease Area, Path Center for Vaccine Innovation & Access
Current

Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA.

Other Affiliations

Ashley Birkett is affiliated with PATH Malaria Vaccine Initiative, PATH

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ashley Birkett. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ashley Birkett's profile does not indicate a business or promotional relationship of any kind between RelSci and Ashley Birkett.